Mangoceuticals, Inc. ( (MGRX) ) has issued an announcement.
Mangoceuticals, Inc. has signed a 12-month consulting agreement with their CFO, Eugene M. Johnston, effective October 1, 2024. Johnston will receive $4,000 monthly and 25,000 shares of company stock, with potential for additional bonuses. The agreement can be terminated under specific conditions and includes provisions for inventions, indemnification, and confidentiality. Johnston is also under a non-solicitation covenant during and post-term.
For an in-depth examination of MGRX stock, go to TipRanks’ Stock Analysis page.
